Primary Cells Market Worth $2.8 Billion : Business Outlook, Growth and Development, Forecast Till 2028
In June 2023, iXCells Biotechnologies entered into an agreement with Tebubio to enhance the distribution of the company's products throughout Europe.
View full press release